Search bioRxiv⌕ Search

Biology subjects

Tie, J.

Publications and source records attributed to Tie, J..

3 recordsLinked to original sources

Bacterial Peptidoglycan Extends Lifespan by Activating Lysosomal Activity through V-ATPase Binding

Lysosomal dysfunction is a hallmark of aging, yet whether microbial components actively regulate this organelle to influence longevity remains unknown. Here, we identify bacterial peptidoglycan (PGN), a major cell wall component degraded by host lysozyme, as an evolutionarily conserved activator of lysosomal function that extends lifespan in both C. elegans and mice. We show that aging leads to an intestinal decline in lysozyme expression, which impairs bacterial cell-wall digestion and results in systemic PGN deficiency. Late-life PGN supplementation (starting at 18 months of age) significantly prolongs mouse lifespan and improves healthspan. Mechanistically, PGN localizes to lysosomes and directly binds V-ATPase subunits, enhancing ATP hydrolysis activity and promoting lysosomal acidification. This effect is abolished by V-ATPase inhibition (bafilomycin A1) or genetic disruption of lysosomal components (cup-5 and vha-12 mutants), confirming that functional V-ATPase is strictly required for lysosomal function and the longevity benefit. Importantly, PGN restores lysosomal acidification in aged cells, alleviates cellular senescence markers, and improves multiple hallmarks of aging including locomotion and muscle integrity. Collectively, these findings reveal an evolutionarily conserved mechanism whereby hosts exploit bacterial cell wall components to maintain cellular homeostasis, establishing a gut microbiome-lysosome-longevity axis with implications for microbiome-based anti-aging interventions.

physiology↗

Microbial Peptidoglycan Engages Autophagy Receptor P62 to Induce Protective Mitophagy in the Liver

Although mitophagy is critical for maintaining mitochondrial integrity and hepatic homeostasis, the microbial-derived signals controlling this process remain unknown. Given the gut microbiotas profound influence on liver pathophysiology, identifying specific bacterial factors that directly regulate hepatocyte mitophagy could unlock novel therapeutic strategies. In this study, we identify bacterial peptidoglycan (PGN)--a conserved cell wall component--as a key activator of mitophagy that protects against hepatocyte death. Through both in vivo and in vitro studies, we demonstrate that either heat-killed Escherichia coli or purified PGN attenuates hepatocyte death. Mechanistically, PGN is internalized by hepatocytes, localizes to mitochondria, and initiates mitophagy via direct interaction with the autophagy adaptor p62/SQSTM1. Genetic ablation of p62 in hepatocytes completely abolishes PGN-induced mitophagy, underscoring the pathways essential role. Strikingly, therapeutic administration of PGN markedly alleviates carbon tetrachloride (CCl4)-induced hepatic fibrosis, reducing collagen deposition and suppressing hepatic stellate cell activation through enhanced autophagic flux. Our work unveils a previously unrecognized host-microbe crosstalk in which PGN acts as a mitophagy inducer, offering a potential therapeutic avenue for liver diseases driven by mitochondrial dysfunction.

cell biology↗

Assessing aneuploidy with repetitive element sequencing.

We report a sensitive PCR-based assay that can detect aneuploidy in samples containing as little as 3 picograms of DNA. Using a single primer pair, we amplified [~]750,000 amplicons distributed throughout the genome Aneuploidy was detected in 49% of liquid biopsies from a total of 883 non-metastatic cancers of eight different types. Combining aneuploidy with somatic mutation detection and eight standard protein biomarkers yielded a median sensitivity of 80% at 99% specificity.

cancer biology↗